Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news


Top of the Hill
Biden and the MA agreement

Posted 20 January 2021 AM

Joe Biden has promised to cut US drug prices just as MA is negotiating a new strategic agreement it has said will be influenced by global decisions.

In a post-Budget interview with Pharma in Focus last year, MA chair Anna Lavelle made it clear that the "impact of global decisions" - in which the US is the leading player - was central to ongoing negotiations with government on the new agreement.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
How not to reform the PBAC
In the face of deep change, is piecemeal enough?
Approvals Action
New registrations for seizures and HIV
Eisai and ViiV add to their core franchises
Special Report
Aust Covid Vaccine Tracker
UPDATE: Distribution of two mRNA vaccines overseas